Author By adminPosted on August 1, 2018April 10, 2024 CBP-1008, World’s First Bi-Engaging Ligand-Mediated Drug Conjugate, Approved for Clinical Trial On August 1, 2018, CBP-1008 for injection, a Class I new drug independently developed by Coherent Biopharma, was approved by SFDA...
